Trevi Therapeutics, Inc.
TRVI
$14.76
-$0.12-0.81%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -13.19M | -8.32M | -11.80M | -12.30M | -10.34M |
| Total Depreciation and Amortization | 34.00K | 31.00K | 38.00K | 38.00K | 37.00K |
| Total Amortization of Deferred Charges | -- | 26.00K | -- | -- | -- |
| Total Other Non-Cash Items | 1.87M | 902.00K | 1.05M | 1.11M | 925.00K |
| Change in Net Operating Assets | -5.40M | -274.00K | -169.00K | 1.05M | -4.10M |
| Cash from Operations | -16.69M | -7.63M | -10.88M | -10.10M | -13.48M |
| Capital Expenditure | -102.00K | 0.00 | -12.00K | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 17.07M | -30.61M | -50.93M | -2.61M | -9.95M |
| Cash from Investing | 16.97M | -30.61M | -50.94M | -2.61M | -9.95M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 0.00 | 0.00 | 0.00 | -11.00K |
| Issuance of Common Stock | 222.00K | 284.00K | 1.12M | 110.76M | 8.94M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 0.00 | 506.00K | -368.00K | -222.00K |
| Cash from Financing | 222.00K | 284.00K | 1.63M | 110.40M | 8.71M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 498.00K | -37.96M | -60.19M | 97.68M | -14.72M |